Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,494 | 1,089 | 984 | 1,393 | 1,762 |
| Operating Income | -1,494 | -1,089 | -984 | -1,393 | -1,762 |
| Other Income | 1,664 | -1,930 | 3,683 | 60 | 70 |
| Pre-tax Income | 170 | -3,019 | 2,699 | -1,333 | -1,692 |
| Net Income Continuous | 170 | -3,019 | 2,699 | -1,333 | -1,692 |
| Net Income | $170 | $-3,019 | $2,699 | $-1,333 | $-1,692 |
| EPS Basic Total Ops | 0.06 | -1.24 | 1.38 | -0.67 | -0.85 |
| EPS Basic Continuous Ops | 0.06 | -1.24 | 1.37 | -0.67 | -0.85 |
| EPS Diluted Total Ops | 0.06 | -1.24 | 1.38 | -0.67 | -0.85 |
| EPS Diluted Continuous Ops | 0.06 | -1.24 | 1.37 | -0.67 | -0.85 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -1.24 | -0.48 | N/A | N/A |
| EBITDA(a) | $-1,461 | $-1,057 | $-959 | $-1,377 | $-1,681 |